Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Non-Interventional Study Evaluating the Long-term Safety of Odevixibat in Patients With Alagille Syndrome (ALGS)

NCT07585097 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT07585097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07585097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Non-Interventional Study Evaluating the Long-term Safety of Odevixibat in Patients With Alagille Syndrome (ALGS)
Lead sponsor
Ipsen
Phase
Observational
Overall status
Recruiting
Start date
July 10, 2026
Completion date
September 30, 2031
Enrollment
30 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

alagille syndrome